Utama › Sistem Imun dan Gangguan › Oregon › Portland
Kajian klinikal Sistem Imun dan Gangguan di Portland, OR
9 kajian untuk Sistem Imun dan Gangguan sedang mencari peserta di lokasi dalam dan sekitar Portland (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- Oregon Health & Science University, Portland
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Mengambil pesertaFasa 3
- Oregon Health & Science University, Portland
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Mengambil pesertaKajian pemerhatian
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Portland VA Medical Center, Portland
- dan 1 lagi
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Mengambil pesertaFasa 3
- Oregon Health & Science University, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- Providence Portland Medical Center, Portland
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Inmagene Site 3, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Mengambil pesertaFasa 2
- Oregon Health and Science University, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Mengambil pesertaFasa 1/2
- Providence Neurological Specialties West, Portland
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Mengambil pesertaFasa 2
- Oregon Health and Science University, Portland
Kajian Sistem Imun dan Gangguan di bandar lain
- Washington, DC13 kajian
- New York City, NY12 kajian
- Boston, MA10 kajian
- Philadelphia, PA10 kajian
- Atlanta, GA9 kajian
- Houston, TX9 kajian
- Chicago, IL8 kajian
- Los Angeles, CA8 kajian
- Cleveland, OH8 kajian
- Seattle, WA6 kajian
- Milwaukee, WI6 kajian
- Cedar Rapids, IA6 kajian
Kajian lain di Portland
- Kanser Paru-paru Bukan Sel Kecil46 kajian
- Kanser (semua jenis)34 kajian
- Kanser Prostat33 kajian
- Kanser Payudara33 kajian
- Kanser Metastatik29 kajian
- Kanser Kolorektal28 kajian
- Kanser Ovari27 kajian
- Kanser Paru-paru26 kajian
- Leukemia Mieloid Akut25 kajian
- Kanser Endometrium24 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher19 kajian
- Kanser Pankreas19 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.